BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 25143126)

  • 1. Prognostic significance of immunophenotypes and a nodular pattern in primary mediastinal large B-cell lymphoma.
    Maeshima AM; Taniguchi H; Miyamoto K; Fukuhara S; Munakata W; Maruyama D; Kim SW; Kobayashi Y; Tobinai K; Kushima R
    Pathol Int; 2014 Aug; 64(8):382-7. PubMed ID: 25143126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The immunophenotypic spectrum of primary mediastinal large B-cell lymphoma reveals prognostic biomarkers associated with outcome.
    Bledsoe JR; Redd RA; Hasserjian RP; Soumerai JD; Nishino HT; Boyer DF; Ferry JA; Zukerberg LR; Harris NL; Abramson JS; Sohani AR
    Am J Hematol; 2016 Oct; 91(10):E436-41. PubMed ID: 27419920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. J chain and myocyte enhancer factor 2B are useful in differentiating classical Hodgkin lymphoma from nodular lymphocyte predominant Hodgkin lymphoma and primary mediastinal large B-cell lymphoma.
    Moore EM; Swerdlow SH; Gibson SE
    Hum Pathol; 2017 Oct; 68():47-53. PubMed ID: 28851661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The utility of CD83, fascin and CD23 in the differential diagnosis of primary mediastinal large B-cell lymphoma versus classic Hodgkin lymphoma.
    Aladily TN; Mansour A; Alsughayer A; Sughayer M; Medeiros LJ
    Ann Diagn Pathol; 2019 Jun; 40():72-76. PubMed ID: 31075666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma.
    Rosenwald A; Wright G; Leroy K; Yu X; Gaulard P; Gascoyne RD; Chan WC; Zhao T; Haioun C; Greiner TC; Weisenburger DD; Lynch JC; Vose J; Armitage JO; Smeland EB; Kvaloy S; Holte H; Delabie J; Campo E; Montserrat E; Lopez-Guillermo A; Ott G; Muller-Hermelink HK; Connors JM; Braziel R; Grogan TM; Fisher RI; Miller TP; LeBlanc M; Chiorazzi M; Zhao H; Yang L; Powell J; Wilson WH; Jaffe ES; Simon R; Klausner RD; Staudt LM
    J Exp Med; 2003 Sep; 198(6):851-62. PubMed ID: 12975453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression pattern of PD-L1 and PD-L2 in classical Hodgkin lymphoma, primary mediastinal large B-cell lymphoma, and gray zone lymphoma.
    Tanaka Y; Maeshima AM; Nomoto J; Makita S; Fukuhara S; Munakata W; Maruyama D; Tobinai K; Kobayashi Y
    Eur J Haematol; 2018 May; 100(5):511-517. PubMed ID: 29377256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MAL is expressed in a subset of Hodgkin lymphoma and identifies a population of patients with poor prognosis.
    Hsi ED; Sup SJ; Alemany C; Tso E; Skacel M; Elson P; Alonso MA; Pohlman B
    Am J Clin Pathol; 2006 May; 125(5):776-82. PubMed ID: 16707382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GATA3 Immunohistochemical Staining in Hodgkin Lymphoma: Diagnostic Utility in Differentiating Classic Hodgkin Lymphoma From Nodular Lymphocyte Predominant Hodgkin Lymphoma and Other Mimicking Entities.
    Kezlarian B; Alhyari M; Venkataraman G; Karner K; Inamdar KV; Menon MP
    Appl Immunohistochem Mol Morphol; 2019 Mar; 27(3):180-184. PubMed ID: 28877074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Primary mediastinal large B-cell lymphoma: a clinicopathologic study of 27 cases].
    Shi QY; Feng X; Chen H; Ma HH; Lu ZF; Shi QL; Zhou XJ; Shen Q
    Zhonghua Bing Li Xue Za Zhi; 2017 Sep; 46(9):607-612. PubMed ID: 28910870
    [No Abstract]   [Full Text] [Related]  

  • 10. The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma.
    Savage KJ; Monti S; Kutok JL; Cattoretti G; Neuberg D; De Leval L; Kurtin P; Dal Cin P; Ladd C; Feuerhake F; Aguiar RC; Li S; Salles G; Berger F; Jing W; Pinkus GS; Habermann T; Dalla-Favera R; Harris NL; Aster JC; Golub TR; Shipp MA
    Blood; 2003 Dec; 102(12):3871-9. PubMed ID: 12933571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Primary mediastinal B-cell lymphoma].
    Coso D; Rey J; Bouabdallah R
    Rev Pneumol Clin; 2010 Feb; 66(1):32-5. PubMed ID: 20207294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mediastinal gray zone lymphoma: clinico-pathological characteristics and outcomes of 99 patients from the Lymphoma Study Association.
    Sarkozy C; Molina T; Ghesquières H; Michallet AS; Dupuis J; Damotte D; Morsschauser F; Parrens M; Martin L; Dartigues P; Stamatoullas A; Hirsch P; Fabiani B; Bouabdallah K; da Silva MG; Maerevoet M; Laurent C; Coiffier B; Salles G; Traverse-Glehen A
    Haematologica; 2017 Jan; 102(1):150-159. PubMed ID: 27758822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical experience with 16 cases of mediastinal lymphoma].
    Toba H; Kondo K; Yoshida M; Kenzaki K; Miyoshi T; Sakiyama S; Tangoku A
    Kyobu Geka; 2008 Feb; 61(2):97-101. PubMed ID: 18268943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mediastinal lymphomas: primary mediastinal (thymic) large B-cell lymphoma versus classical Hodgkin lymphoma, histopathologic dilemma solved?
    Pervez S; Khawaja RD
    Pathol Res Pract; 2010 Jun; 206(6):365-7. PubMed ID: 20185248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary mediastinal large B-cell lymphoma, classic Hodgkin lymphoma presenting in the mediastinum, and mediastinal gray zone lymphoma: what is the oncologist to do?
    Grant C; Dunleavy K; Eberle FC; Pittaluga S; Wilson WH; Jaffe ES
    Curr Hematol Malig Rep; 2011 Sep; 6(3):157-63. PubMed ID: 21590365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absolute Monocyte Count and Lymphocyte-Monocyte Ratio Predict Outcome in Nodular Sclerosis Hodgkin Lymphoma: Evaluation Based on Data From 1450 Patients.
    Tadmor T; Bari A; Marcheselli L; Sacchi S; Aviv A; Baldini L; Gobbi PG; Pozzi S; Ferri P; Cox MC; Cascavilla N; Iannitto E; Federico M; Polliack A
    Mayo Clin Proc; 2015 Jun; 90(6):756-64. PubMed ID: 26046410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of Grb2 distinguishes classical Hodgkin lymphomas from primary mediastinal B-cell lymphomas and other diffuse large B-cell lymphomas.
    Miles RR; Mankey CC; Seiler CE; Smith LB; Teruya-Feldstein J; Hsi ED; Elenitoba-Johnson KS; Lim MS
    Hum Pathol; 2009 Dec; 40(12):1731-7. PubMed ID: 19716163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathology case of the month. A mediastinal mass. Malignant lymphoma, composite (nodular sclerosis Hodgkin lymphoma and diffuse large B-cell lymphoma).
    Wei EX; Flamholz RB; Lowery-Nordberg M; Veillon DM; Behm W; Heldmann M; Cotelingam JD
    J La State Med Soc; 2004; 156(6):294-7. PubMed ID: 15688668
    [No Abstract]   [Full Text] [Related]  

  • 19. Prognostic significance of CD20 expression and Epstein-Barr virus (EBV) association in classical Hodgkin lymphoma in Japan: a clinicopathologic study.
    Elsayed AA; Asano N; Ohshima K; Izutsu K; Kinoshita T; Nakamura S
    Pathol Int; 2014 Jul; 64(7):336-45. PubMed ID: 25047504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathological analysis of mediastinal large B-cell lymphoma and classical Hodgkin lymphoma of the mediastinum.
    Yamamoto W; Nakamura N; Tomita N; Ishii Y; Takasaki H; Hashimoto C; Motomura S; Yamazaki E; Ohshima R; Numata A; Ishigatsubo Y; Sakai R
    Leuk Lymphoma; 2013 May; 54(5):967-72. PubMed ID: 23020783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.